Teriflunomide shows promise for MS treatment in phase III trial

被引：1

|

作者：

Heather Wood

机构：

来源：

Nature Reviews Neurology | 2011年 / 7卷 / 12期

关键词：

D O I：

10.1038/nrneurol.2011.184

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：657 / 657

相关论文

共 50 条

[41] TRIAL WATCH Phase III promise for oral multiple sclerosis therapy
不详
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (02) : 98 - 98
[42] Pasireotide shows efficacy in Phase III trial for Cushing's disease
不详
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (06) : 796 - 796
[43] First clinical trial of a new treatment for familial amyotrophic lateral sclerosis shows promise
Mansbridge, Michael
NEURODEGENERATIVE DISEASE MANAGEMENT, 2013, 3 (03) : 200 - 200
[44] Tildrakizumab shows promise in phase IIb study
Onuora S.
Nature Reviews Rheumatology, 2021, 17 (7) : 378 - 378
[45] Teriflunomide treatment reduces B cells in patients with MS
Gandoglia, Ilaria
Ivaldi, Federico
Laroni, Alice
Benvenuto, Federica
Solaro, Claudio
Mancardi, Gianluigi
de Rosbo, Nicole Kerlero
Uccelli, Antonio
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2017, 4 (06):
[46] Hepatitis A vaccine trial in Nicaraguan children shows promise
Orellana, C
LANCET INFECTIOUS DISEASES, 2003, 3 (10): : 605 - 605
[47] Trial shows promise for sublingual immunotherapy for peanut allergy
Patience, Jonny
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (03) : 197 - 197
[48] Novel, synthetic molecule shows promise in preclinical trial
不详
EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 703 - 703
[49] Efficacy of oral teriflunomide in multiple sclerosis with relapses: cognitive outcomes from a phase III trial (TEMSO)
Miller, A.
O'Connor, P.
Wolinsky, J.
Confavreux, C.
Comi, G.
Kappos, L.
Olsson, T.
Truffinet, P.
Wang, L.
Freedman, M.
MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S182 - S182
[50] Experimental Treatment for Batten Disease Shows Promise
Kuehn, Bridget M.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (20): : 2140 - 2140

← 1 2 3 4 5 →